- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02727426
Dietary Salt and Microvascular Function
Influence of High Salt Diet on Microvascular Reactivity in Young Healthy Subjects
It is well accepted that high-salt (HS) intake is an essential risk factor in development and progression of hypertension. Results of some recent studies suggest that some of the deleterious effects of a HS diet are independent of elevated blood pressure (BP) and may occur in normotensive individuals and are associated with impaired endothelial function. However, the effects of acute salt loading on endothelial function and vascular reactivity in young healthy individuals are still scarce and inconsistent.
The purpose of present study is to determine whether one week of HS intake affects microvascular reactivity in young healthy subjects without changes in BP. In addition, the investigators sought to evaluate if potential HS diet-induced microvascular dysfunction is associated with changes in oxidative stress level and/or with modification of immunological response in young healthy subjects.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Ana - Stupin, MD, PhD
- Phone Number: +385915134958
- Email: anacavka@mefos.hr
Study Contact Backup
- Name: Ines - Drenjancevic, MD, PhD
- Phone Number: +385912241406
- Email: ines.drenjancevic@mefos.hr
Study Locations
-
-
-
Osijek, Croatia, 31000
- Recruiting
- Faculty of Medicine Osijek, Laboratory for Clinical and Sport Physiology
-
Contact:
- Ana Stupin, MD, PhD
- Phone Number: '385915134598
- Email: anacavka@mefos.hr
-
Contact:
- Ines Drenjancevic, MD, PhD
- Phone Number: '385912241406
- Email: ines.drenjancevic@mefos.hr
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- healthy volunteers
Exclusion Criteria:
- oral contraceptives
- drugs that could affect the endothelium
- hypertension
- coronary artery disease
- diabetes
- hyperlipidaemia
- renal impairment
- cerebrovascular and peripheral artery disease
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Non-Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: low salt diet
All subjects will be instructed to maintain a low-sodium (LS) diet, with an intake of less than 2.3 g of salt per day (DASH eating plan; US Department of Health and Human Services, 2006) for 7 days (washout period).
|
Intake of less than 2.3 g of salt per day for 7 days.
|
Experimental: high salt diet
After washout period, all subjects will be instructed to maintain a high-sodium (HS) diet, with an intake of 11.2 g of salt per day for 7 days.
|
Intake of 11.2 g of salt per day for 7 days.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
microvascular reactivity
Time Frame: two weeks after starting the protocol
|
Cutaneous microvascular blood flow will be measured by Laser Doppler Flowmetry in response to vascular occlusion (post occlusive reactive hyperemia- PORH) and in response to iontophoresis of acetylcholine (ACh) (endothelium dependent vasodilation) before and after diet protocols.
|
two weeks after starting the protocol
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
oxidative stress
Time Frame: two weeks after starting the protocol
|
As direct indicator of oxidative stress, byproducts of lipid peroxidation - TBARS method (Thiobarbituric Acid Reactive Substances) with malondialdehyde (MDA) as standard (µM MDA) will be measured before and after LS and HS diet protocol (spectrophotometric method).
|
two weeks after starting the protocol
|
modification of immunological response by high salt diet
Time Frame: two weeks after starting the protocol
|
Activated monocytes/macrophages and neutrophils will be measured by flow cytometry, with distinction of subpopulation of monocytes/macrophages (classical/nonclassical), their activation and the expression of the integrin LFA-1 (lymphocyte function-associated antigen 1) and VLA-4 (Very Late Antigen-4) - ligands VCAM-1 (vascular cell adhesion molecule 1 ) and ICAM-1 (vascular cell adhesion molecule 1).
|
two weeks after starting the protocol
|
antioxidant capacity
Time Frame: two weeks after starting the protocol
|
As an indicator of antioxidant capacity, the ferric reducing ability of plasma - the FRAP assay (Ferric reducing ability of plasma) with Trolox used as standard (mM Trolox) will be measured before and after LS and HS diet protocol (spectrophotometric method).
|
two weeks after starting the protocol
|
Collaborators and Investigators
Investigators
- Principal Investigator: Ines Drenjancevic, MD, PhD, Faculty of Medicine, University of Osijek, Croatia
Publications and helpful links
General Publications
- Cavka A, Cosic A, Jukic I, Jelakovic B, Lombard JH, Phillips SA, Seric V, Mihaljevic I, Drenjancevic I. The role of cyclo-oxygenase-1 in high-salt diet-induced microvascular dysfunction in humans. J Physiol. 2015 Dec 15;593(24):5313-24. doi: 10.1113/JP271631. Epub 2015 Dec 7.
- Cavka A, Jukic I, Ali M, Goslawski M, Bian JT, Wang E, Drenjancevic I, Phillips SA. Short-term high salt intake reduces brachial artery and microvascular function in the absence of changes in blood pressure. J Hypertens. 2016 Apr;34(4):676-84. doi: 10.1097/HJH.0000000000000852.
- Cavka A, Cosic A, Grizelj I, Koller A, Jelakovic B, Lombard JH, Phillips SA, Drenjancevic I. Effects of AT1 receptor blockade on plasma thromboxane A2 (TXA2) level and skin microcirculation in young healthy women on low salt diet. Kidney Blood Press Res. 2013;37(4-5):432-42. doi: 10.1159/000355723. Epub 2013 Oct 13.
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 215861071012
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Salt; Excess
-
Josip Juraj Strossmayer University of OsijekRecruitingPregnancy Related | Salt; ExcessCroatia
-
Mahidol UniversityUnknownHypertension | Salt; ExcessThailand
-
Mahidol UniversityWorld Health Organization; Thai health promotion foundation.RecruitingHypertension | Salt; ExcessThailand
-
Universidade do PortoFundação para a Ciência e a Tecnologia; Centro Hospitalar De São João, E.P.E.; Instituto Nacional de Saúde Doutor Ricardo JorgeUnknownHypertension | Salt; ExcessPortugal
-
Kecioren Education and Training HospitalCompletedLens Opacities | Salt Hypertension From Excess Dietary SaltTurkey
-
Auburn UniversityUniversity of Missouri-Columbia; University of UtahRecruiting
-
Wake Forest University Health SciencesNational Heart, Lung, and Blood Institute (NHLBI)RecruitingBlood Pressure Disorders | Salt; ExcessUnited States
-
University of Alabama at BirminghamRecruitingTiming of Sodium Intake and Nocturnal Sodium Excretion and Blood Pressure in Obese African AmericansHypertension | Obesity | Salt; Excess | Circadian DysregulationUnited States
-
Vanderbilt University Medical CenterRecruitingInflammation | High Blood Pressure | Salt; ExcessUnited States
-
Vanderbilt University Medical CenterCompletedObesity | Cardiovascular Risk Factor | Salt; ExcessUnited States
Clinical Trials on Low Salt (LS) diet
-
University of Southern DenmarkOdense University Hospital; Beckett Foundation; Danish Diabetes AcademyCompleted
-
Brigham and Women's HospitalTerminatedAutoimmunity | Sodium Chloride | Salt Intake | Th17 Helper Immune CellsUnited States
-
University of MichiganRenal Research InstituteCompletedKidney DiseaseUnited States
-
Vanderbilt UniversityCompleted
-
Vanderbilt University Medical CenterCompletedObesity | Cardiovascular Risk Factor | Salt; ExcessUnited States
-
Aga Khan UniversityWellcome TrustUnknown
-
Wolfson Medical CenterUnknown
-
Hospital Clínico Universitario de ValladolidUnknown
-
Max Planck Institute for Metabolism ResearchYale UniversityCompletedBehavior, Eating
-
Josip Juraj Strossmayer University of OsijekRecruitingPsoriasis VulgarisCroatia